Glaucoma
±¹³»µµ¼­(2) | ¿Ü±¹µµ¼­(12)
Glaucoma ÃÑ 14°³ÀÇ »óǰÀÌ ÀÖ½À´Ï´Ù.
Thieme
Glaucoma affects millions of people worldwide and is the second leading cause of blindness. Major advances in innovative surgical techniques, collectively termed minimally invasive glaucoma surgery (MIGS), have revolutionized the field. These groundbreaki
173,000 ¡é
170,000¿ø
ÃÖ½ÅÀÇÇлç
5³â ¸¸¿¡ ³ì³»Àå ±³°ú¼­ 6ÆÇÀÌ Ãâ°£µÇ¾ú½À´Ï´Ù.
»õ·Î¿î ½Ã´ë¿¡ °É¸ÂÀº üÁ¦¿Í ÃÖ½ÅÀÇ ±¹³»¿Ü ³ì³»Àå Á¤º¸¸¦ Æ÷ÇÔÇϵµ·Ï °³Á¤
ÇÏ¿´½À´Ï´Ù.
³ì³»ÀåÀ» °øºÎÇÏ´Â ¾È°ú ¼±»ý´Ô²² Å« µµ¿òÀÌ µÇ±â¸¦ ±â´ëÇÕ´Ï´Ù.
140,000 ¡é
135,000¿ø
A.A.O
Provides a comprehensive discussion of glaucoma, including epidemiology and the social and economic impacts of the disease; hereditary and genetic factors; intraocular pressure and aqueous humor dynamics; and clinical evaluation and surgical therapy
200,000 ¡é
180,000¿ø
SLACK
Curbside Consultation in Glaucoma: 49 Clinical Questions has been updated into a Second Edition!

The Second Edition contains new questions and is completely updated!


108,000 ¡é
90,000¿ø
SAUNDERS
As the irreversible effects of glaucoma can lead to blindness, there is high demand for early diagnosis and an ongoing need for practitioners to adopt new and evolving medical and surgical treatment options to improve patient outcomes. Glaucoma, Second Ed
480,000 ¡é
450,000¿ø
MOSBY
112,000 ¡é
30,000¿ø
MOSBY
375,000 ¡é
350,000¿ø
Springer
140,000 ¡é
137,000¿ø
Lippincott
283,200 ¡é
264,000¿ø
90,000 ¡é
90,000¿ø
1 [2]

ÁÖ¼Ò : °æ±â °í¾ç½Ã Àϻ굿±¸ Áß¾Ó·Î1305-30(ÀåÇ×µ¿ 775-1) ÀÏ»ê»ï¼º¸¶ÀÌ´Ù½º¿ÀÇǽºÅÚ 714È£ | »ç¾÷ÀÚµî·Ï¹øÈ£ : 208-98-50853
Åë½ÅÆÇ¸Å¾÷½Å°í¹øÈ£ : 2012-°í¾çÀϻ굿-0516È£ | °³ÀÎÁ¤º¸°ü¸®ÀÚ : Á¤»ó±Ô | ´ëÇ¥ : Á¤»ó±Ô | »óÈ£¸í : µµ¼­ÃâÆÇ ³»¿ÜÇмú
ÀüÈ­¹øÈ£ : 031-902-7439 | ÆÑ½º¹øÈ£ : 031-902-0719 | ¸ÞÀÏ : naewae-haksool@hanmail.net
Samsung Midas Officetel 714ho, 1305-30, Jungangro IlsanDong-gu, Goyang-si Gyeonggi-do 410-837 Korea
Tel. 82-31-902-7439 Fax. 82-31-902-0719    Mobile. 82-10-3763-7439

Copyright ¨Ï www.naewaehs.com All right reserved